デフォルト表紙
市場調査レポート
商品コード
1618748

次世代IVD市場:製品、用途、エンドユーザー別-2025-2030年の世界予測

Next-Generation IVD Market by Product (Consumables, Instruments, Software), Application (Autoimmune Diseases, Cardiology, Diabetes), End-user - Global Forecast 2025-2030


出版日
発行
360iResearch
ページ情報
英文 182 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.30円
次世代IVD市場:製品、用途、エンドユーザー別-2025-2030年の世界予測
出版日: 2024年12月01日
発行: 360iResearch
ページ情報: 英文 182 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

次世代IVD市場の2023年の市場規模は625億2,000万米ドルで、2024年には656億米ドルに達すると予測され、CAGR 5.23%で成長し、2030年には893億9,000万米ドルに達すると予測されています。

次世代体外診断薬(IVD)市場は、疾患の正確な検出、モニタリング、治療を目的とした高度な技術やテクノロジーを特徴としています。その範囲と定義は、分子診断、ポイントオブケア検査、AIやデータ分析で強化された統合診断ツールなど、革新的な診断オプションを幅広く包含しています。このような次世代IVDツールの必要性は、早期かつ正確な診断、個別化医療アプローチ、慢性疾患の蔓延に対する需要の高まりに後押しされています。その用途は臨床診断、腫瘍学、感染症、遺伝子検査に及び、病院、診断研究所、研究機関などのエンドユーザーにサービスを提供しています。市場成長は主に、技術的進歩、非侵襲的診断の台頭、ヘルスケアコスト削減の世界的重視の影響を受けています。ウェアラブル診断の統合や、意思決定のためのリアルタイムデータへの依存の高まりからビジネスチャンスが生まれます。企業は、強固な研究開発への投資、新興市場への進出、技術力強化のための戦略的パートナーシップの形成により、これらの機会をさらに活用することができます。逆に市場の限界としては、先進的な診断機器の高額なコストや厳しい規制当局の承認プロセスなどがあり、これらは技術革新や普及の妨げになる可能性があります。また、データのプライバシーに関する懸念や、さまざまなヘルスケアシステム間での技術的相互運用性の問題も課題となっています。これらの課題を克服するためには、手頃な価格で迅速な診断ソリューション、使いやすいプラットフォームの強化、技術統合を合理化する協力関係の促進に焦点を当てたイノベーションが必要です。さらに、予測診断と個別化された患者ケアのための人工知能アプリケーションを探求することで、新たな研究の道を開くことができます。企業は、市場主導型のアプローチを重視し、地域のヘルスケア力学を理解し、市場の複雑性を乗り切る適応性の高いビジネスモデルに注力することで、洞察を得ることができます。IVDの情勢が進化する中、企業は俊敏性を維持し、競争優位性を維持するために、漸進的イノベーションと画期的イノベーションの両方に投資すべきです。

主な市場の統計
基準年[2023] 625億2,000万米ドル
予測年[2024] 656億米ドル
予測年[2030] 893億9,000万米ドル
CAGR(%) 5.23%

市場力学:急速に進化する次世代IVD市場の主要市場インサイトを公開

次世代IVD市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

  • 市場促進要因
    • 世界の高齢化の進展と慢性疾患の蔓延
    • 精密医療を向上させるための次世代IVD検査の採用増加
  • 市場抑制要因
    • 患者ケアを向上させるための適切なヘルスケア専門家の必要性
  • 市場機会
    • 次世代体外診断用医薬品に使用される技術の進歩
    • 体外診断用医薬品業界におけるポイントオブケア(POC)検査の採用増加
  • 市場の課題
    • 次世代IVDに影響を与える厳しい規制

ポーターのファイブフォース:次世代IVD市場をナビゲートする戦略ツール

ポーターのファイブフォース」フレームワークは、市場情勢の競合情勢を把握するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析:次世代IVD市場における外部からの影響の把握

外部マクロ環境要因は、次世代IVD市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析次世代IVD市場における競合情勢の把握

次世代IVD市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス次世代IVD市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、次世代IVD市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨次世代IVD市場における成功への道筋を描く

次世代IVD市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています:

1.市場の浸透度:現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度:新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化:最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報:競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション:将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています:

1.現在の市場規模と今後の成長予測は?

2.最高の投資機会を提供する製品、セグメント、地域はどこか?

3.市場を形成する主な技術動向と規制の影響とは?

4.主要ベンダーの市場シェアと競合ポジションは?

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か?

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 世界中で高齢化が進み、慢性疾患の罹患率も増加している
      • 次世代IVD検査の採用拡大による精密医療の向上
    • 抑制要因
      • 患者ケアの改善には適切なヘルスケア専門家が必要
    • 機会
      • 次世代IVDに使用される技術の進歩
      • IVD業界におけるポイントオブケア(POC)検査の採用増加
    • 課題
      • 次世代IVDに影響を与える厳しい規制
  • 市場セグメンテーション分析
    • 製品:体外診断における消耗品の活用による精度と再現性の確保
    • 用途:幅広い感染症や慢性疾患に対応するための次世代IVD技術の進歩
  • ポーターのファイブフォース分析
  • PESTEL分析
    • 政治的
    • 経済
    • 社交
    • 技術的
    • 法律上
    • 環境

第6章 次世代IVD市場:製品別

  • 消耗品
  • 機器
  • ソフトウェア

第7章 次世代IVD市場:用途別

  • 自己免疫疾患
  • 心臓病学
  • 糖尿病
  • 感染症
  • 腎臓学
  • 腫瘍学

第8章 次世代IVD市場:エンドユーザー別

  • 学術・調査機関
  • 診断検査室
  • 病院・クリニック

第9章 南北アメリカの次世代IVD市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第10章 アジア太平洋地域の次世代IVD市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第11章 欧州・中東・アフリカの次世代IVD市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第12章 競合情勢

  • 市場シェア分析2023
  • FPNVポジショニングマトリックス, 2023
  • 競合シナリオ分析
    • 戦略的コラボレーション:イルミナとデバイサー・ダイアグノスティクスがIVDイノベーションの道を切り開く
    • Fapon BiotechはIVDの情勢を前進させ、次世代治療薬の拡大を目指す
    • ウォーターズコーポレーション、革新的なXevo TQ Absolute IVD質量分析計を発表
  • 戦略分析と提言

企業一覧

  • ABL SA Group
  • Agilent Technologies Inc.
  • Archer by Integrated DNA Technologies, Inc.
  • Becton, Dickinson and Company
  • Biomerieux SA
  • BioVendor-Laboratorni medicina A.S.
  • Cerba Research NV
  • Curetis N.V.
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd.
  • Fapon Biotech Inc.
  • Fulgent Genetics, Inc.
  • Geneseeq Technology Inc.
  • Genomic Labs Ltd.
  • Illumina, Inc.
  • Invivoscribe, Inc.
  • NGenBio Co., Ltd.
  • Otsuka Pharmaceutical Co., Ltd.
  • Pillar Biosciences Inc.
  • QIAGEN GmbH
  • Sophia Genetics SA
  • Sysmex Europe SE
  • Tempus Labs, Inc.
  • Thermo Fisher Scientific Inc.
  • Trivitron Healthcare
  • Vela Diagnostics Holding Pte Ltd.
図表

LIST OF FIGURES

  • FIGURE 1. NEXT-GENERATION IVD MARKET RESEARCH PROCESS
  • FIGURE 2. NEXT-GENERATION IVD MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL NEXT-GENERATION IVD MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS NEXT-GENERATION IVD MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS NEXT-GENERATION IVD MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES NEXT-GENERATION IVD MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES NEXT-GENERATION IVD MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC NEXT-GENERATION IVD MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC NEXT-GENERATION IVD MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION IVD MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION IVD MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. NEXT-GENERATION IVD MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. NEXT-GENERATION IVD MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. NEXT-GENERATION IVD MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL NEXT-GENERATION IVD MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. NEXT-GENERATION IVD MARKET DYNAMICS
  • TABLE 7. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY DIABETES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY NEPHROLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS NEXT-GENERATION IVD MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 35. MEXICO NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 36. MEXICO NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES NEXT-GENERATION IVD MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. ASIA-PACIFIC NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. ASIA-PACIFIC NEXT-GENERATION IVD MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 46. AUSTRALIA NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 47. AUSTRALIA NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. AUSTRALIA NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. CHINA NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. CHINA NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. CHINA NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. INDIA NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 53. INDIA NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. INDIA NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 55. INDONESIA NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. INDONESIA NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. INDONESIA NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. JAPAN NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 59. JAPAN NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. JAPAN NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. MALAYSIA NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. MALAYSIA NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. MALAYSIA NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. PHILIPPINES NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 65. PHILIPPINES NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. PHILIPPINES NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. SINGAPORE NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 68. SINGAPORE NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. SINGAPORE NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. SOUTH KOREA NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. SOUTH KOREA NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. SOUTH KOREA NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. TAIWAN NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 74. TAIWAN NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. TAIWAN NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. THAILAND NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. THAILAND NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. THAILAND NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. VIETNAM NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 80. VIETNAM NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. VIETNAM NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION IVD MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 86. DENMARK NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. DENMARK NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. DENMARK NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. EGYPT NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 90. EGYPT NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. EGYPT NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. FINLAND NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. FINLAND NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. FINLAND NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. FRANCE NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. FRANCE NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. FRANCE NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. GERMANY NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. GERMANY NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. GERMANY NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. ISRAEL NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. ISRAEL NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. ISRAEL NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. ITALY NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 105. ITALY NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. ITALY NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. NETHERLANDS NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 108. NETHERLANDS NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. NETHERLANDS NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 110. NIGERIA NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 111. NIGERIA NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. NIGERIA NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 113. NORWAY NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 114. NORWAY NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. NORWAY NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. POLAND NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 117. POLAND NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. POLAND NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. QATAR NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 120. QATAR NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. QATAR NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 122. RUSSIA NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 123. RUSSIA NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. RUSSIA NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. SAUDI ARABIA NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 126. SAUDI ARABIA NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. SAUDI ARABIA NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH AFRICA NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH AFRICA NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH AFRICA NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 131. SPAIN NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 132. SPAIN NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. SPAIN NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 134. SWEDEN NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 135. SWEDEN NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. SWEDEN NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. SWITZERLAND NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 138. SWITZERLAND NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. SWITZERLAND NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 140. TURKEY NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 141. TURKEY NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. TURKEY NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED ARAB EMIRATES NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED ARAB EMIRATES NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED ARAB EMIRATES NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED KINGDOM NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED KINGDOM NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 148. UNITED KINGDOM NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 149. NEXT-GENERATION IVD MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 150. NEXT-GENERATION IVD MARKET, FPNV POSITIONING MATRIX, 2023
目次
Product Code: MRR-2E76C3E47F6A

The Next-Generation IVD Market was valued at USD 62.52 billion in 2023, expected to reach USD 65.60 billion in 2024, and is projected to grow at a CAGR of 5.23%, to USD 89.39 billion by 2030.

The next-generation in vitro diagnostics (IVD) market is characterized by advanced techniques and technologies aimed at precise detection, monitoring, and treatment of diseases. The scope and definition encompass a wide range of innovative diagnostic options, such as molecular diagnostics, point-of-care tests, and integrated diagnostic tools enhanced with AI and data analytics. The necessity for these next-gen IVD tools is driven by an increasing demand for early and accurate diagnosis, personalized medicine approaches, and the escalating prevalence of chronic diseases. Their application spans clinical diagnostics, oncology, infectious diseases, and genetic testing, serving end-users like hospitals, diagnostic laboratories, and research institutes. Market growth is primarily influenced by technological advancements, the rise of non-invasive diagnostics, and the global emphasis on healthcare cost reduction. Opportunities arise from the integration of wearable diagnostics and the growing reliance on real-time data for decision-making. Companies could further leverage these opportunities by investing in robust R&D, expanding into emerging markets, and forming strategic partnerships to enhance technological capabilities. Conversely, market limitations include high costs of advanced diagnostic equipment and stringent regulatory approval processes, which could impede innovation and deployment. Challenges also consist of data privacy concerns and technological interoperability issues among varied healthcare systems. To overcome these challenges, there is a need for innovations focusing on affordable and rapid diagnostic solutions, enhancement of user-friendly platforms, and fostering collaborations that streamline technological integration. Additionally, exploring artificial intelligence applications for predictive diagnostics and personalized patient care can open new research avenues. Businesses can gain insights by emphasizing a market-driven approach, understanding regional healthcare dynamics, and focusing on adaptable business models to navigate market complexities. As the IVD landscape evolves, companies should remain agile, investing in both incremental and breakthrough innovations to maintain competitive advantage.

KEY MARKET STATISTICS
Base Year [2023] USD 62.52 billion
Estimated Year [2024] USD 65.60 billion
Forecast Year [2030] USD 89.39 billion
CAGR (%) 5.23%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Next-Generation IVD Market

The Next-Generation IVD Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising aging population across the globe and growing prevalence of chronic diseases
    • Increasing adoption next generation IVD tests to improve precision medicine
  • Market Restraints
    • Need of appropriate healthcare professionals to improve patient care
  • Market Opportunities
    • Advancements in technology used for next generation IVD
    • Rising adoption of Point-of-care (POC) testing in IVD industry
  • Market Challenges
    • Stringent regulations impacting the next generation IVD

Porter's Five Forces: A Strategic Tool for Navigating the Next-Generation IVD Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Next-Generation IVD Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Next-Generation IVD Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Next-Generation IVD Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Next-Generation IVD Market

A detailed market share analysis in the Next-Generation IVD Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Next-Generation IVD Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Next-Generation IVD Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Next-Generation IVD Market

A strategic analysis of the Next-Generation IVD Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Next-Generation IVD Market, highlighting leading vendors and their innovative profiles. These include ABL SA Group, Agilent Technologies Inc., Archer by Integrated DNA Technologies, Inc., Becton, Dickinson and Company, Biomerieux SA, BioVendor - Laboratorni medicina A.S., Cerba Research NV, Curetis N.V., Danaher Corporation, F. Hoffmann-La Roche Ltd., Fapon Biotech Inc., Fulgent Genetics, Inc., Geneseeq Technology Inc., Genomic Labs Ltd., Illumina, Inc., Invivoscribe, Inc., NGenBio Co., Ltd., Otsuka Pharmaceutical Co., Ltd., Pillar Biosciences Inc., QIAGEN GmbH, Sophia Genetics SA, Sysmex Europe SE, Tempus Labs, Inc., Thermo Fisher Scientific Inc., Trivitron Healthcare, and Vela Diagnostics Holding Pte Ltd..

Market Segmentation & Coverage

This research report categorizes the Next-Generation IVD Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Consumables, Instruments, and Software.
  • Based on Application, market is studied across Autoimmune Diseases, Cardiology, Diabetes, Infectious Diseases, Nephrology, and Oncology.
  • Based on End-user, market is studied across Academic & Research Institutions, Diagnostic Laboratories, and Hospitals & Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising aging population across the globe and growing prevalence of chronic diseases
      • 5.1.1.2. Increasing adoption next generation IVD tests to improve precision medicine
    • 5.1.2. Restraints
      • 5.1.2.1. Need of appropriate healthcare professionals to improve patient care
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements in technology used for next generation IVD
      • 5.1.3.2. Rising adoption of Point-of-care (POC) testing in IVD industry
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulations impacting the next generation IVD
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Utilization of consumables in an in-vitro diagnostics to ensure the accuracy and reproducibility
    • 5.2.2. Application: Advancement in the next-generation IVD technology to cater wide array of infectious and chronic diseases
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Next-Generation IVD Market, by Product

  • 6.1. Introduction
  • 6.2. Consumables
  • 6.3. Instruments
  • 6.4. Software

7. Next-Generation IVD Market, by Application

  • 7.1. Introduction
  • 7.2. Autoimmune Diseases
  • 7.3. Cardiology
  • 7.4. Diabetes
  • 7.5. Infectious Diseases
  • 7.6. Nephrology
  • 7.7. Oncology

8. Next-Generation IVD Market, by End-user

  • 8.1. Introduction
  • 8.2. Academic & Research Institutions
  • 8.3. Diagnostic Laboratories
  • 8.4. Hospitals & Clinics

9. Americas Next-Generation IVD Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Next-Generation IVD Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Next-Generation IVD Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Strategic Collaboration: Illumina and Devyser Diagnostics Forge Path in IVD Innovation
    • 12.3.2. Fapon Biotech Advances IVD Landscape and Targets Next-Generation Therapeutics Expansion
    • 12.3.3. Waters Corporation Introduces Revolutionary Xevo TQ Absolute IVD Mass Spectrometer
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. ABL SA Group
  • 2. Agilent Technologies Inc.
  • 3. Archer by Integrated DNA Technologies, Inc.
  • 4. Becton, Dickinson and Company
  • 5. Biomerieux SA
  • 6. BioVendor - Laboratorni medicina A.S.
  • 7. Cerba Research NV
  • 8. Curetis N.V.
  • 9. Danaher Corporation
  • 10. F. Hoffmann-La Roche Ltd.
  • 11. Fapon Biotech Inc.
  • 12. Fulgent Genetics, Inc.
  • 13. Geneseeq Technology Inc.
  • 14. Genomic Labs Ltd.
  • 15. Illumina, Inc.
  • 16. Invivoscribe, Inc.
  • 17. NGenBio Co., Ltd.
  • 18. Otsuka Pharmaceutical Co., Ltd.
  • 19. Pillar Biosciences Inc.
  • 20. QIAGEN GmbH
  • 21. Sophia Genetics SA
  • 22. Sysmex Europe SE
  • 23. Tempus Labs, Inc.
  • 24. Thermo Fisher Scientific Inc.
  • 25. Trivitron Healthcare
  • 26. Vela Diagnostics Holding Pte Ltd.